Os Therapies Incorporated's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Os Therapies Incorporated's ROA in the second quarter of 2026?
Os Therapies Incorporated recorded a cumulative net loss of $-55 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -286.39%.

However, within the Healthcare sector 912 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4626, from total ROA ranking in the first quarter of 2026 at 5350.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	152.69 %	71.75 %	511.71 %	352.81 %	668.17 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-55	-50	-44	-20	-16
Return On Assets (TTM)	-286.39 %	-333.88 %	-306.18 %	-278.89 %	-294.47 %
OSTX's Total Ranking	# 4626	# 5350	# 4681	# 4748	# 4866
Total Assets (TTM) in million	26	7	34	9	10
Seq. Total Assets Change	256.94 %	-78.46 %	278.43 %	-13.16 %	142.6 %
Seq. Net Income Change	-	-	-	-	-

OSTX's 5 Years Annual ROA >> Back to OSTX Management Effectiveness >> Compare OSTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 436
Sector	# 913
Overall	# 4581

Return On Assets Statistics
High	Average	Low
-278.89 %	-465.89 %	-661.42 %
(Sep 30 2025)		(Jun 30 2026)

Financial Statements
Os Therapies Incorporated's Assets	$ 26 million	OSTX's Balance sheet
Os Therapies Incorporated's Income	$ -9 million	Quarterly OSTX's Income Statement
OSTX's Income by Division		See OSTX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	511.71 %	-	-	-	-
Total Assets in million	34	6	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-29	-11	0	0	0
Annual Return On Assets	-84.87 %	-195.98 %	-	-	-

OSTX's 5 Years Annual ROA >> Back to OSTX Management Effectiveness >> Compare OSTX ROA to its Competitors

More Return On Assets Ratios
OSTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OSTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OSTX's Competitors
Subscribers only: Roa for Os Therapies Incorporated's Suppliers
Subscribers only: Return On Assets for OSTX's Customers

You may also want to know
OSTX's Roi	OSTX's Inventory Turnover Ratio	OSTX's Growth Rates	OSTX's Dividend Comparisons
	OSTX's Profitability Ratios	OSTX's Asset Turnover Ratio	OSTX's Dividend Growth
OSTX's Roe	OSTX's Valuation Ratios	OSTX's Financial Strength Ratios	OSTX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-17T07:29:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.